Literature DB >> 8342391

Preliminary report on the development of a disease-specific instrument for assessing quality of life of adults with growth hormone deficiency.

S M Hunt1, S P McKenna, L C Doward.   

Abstract

It is notable that many of the feelings described by the people in the sample are similar to those experienced at times by people who do not suffer from GHD, that is, lapses of memory, feeling drained of energy, loss of temper, loss of motivation, difficulty in concentrating, forgetfulness and having a tendency to gain weight. Adults with GHD, however, appear to suffer these problems more frequently and to a more extreme degree than other people. It is clear that the range of problems that afflict people with GHD is great, and that the repercussions affect virtually all aspects of their lives. The results from these interviews will form the basis of a measure designed specifically to assess the quality of life of patients with GHD, and to determine the changes in quality of life after treatment with GH.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8342391

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  10 in total

Review 1.  Long-term growth hormone replacement therapy in hypopituitary adults.

Authors:  Johan Verhelst; Roger Abs
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  The international development of the RGHQoL: a quality of life measure for recurrent genital herpes.

Authors:  L C Doward; S P McKenna; T Kohlmann; M Niero; D Patrick; B Spencer; H Thorsen
Journal:  Qual Life Res       Date:  1998-02       Impact factor: 4.147

Review 3.  Quality-of-life assessment of adults with growth hormone deficiency. Implications for drug therapy.

Authors:  S P McKenna; L C Doward
Journal:  Pharmacoeconomics       Date:  1994-11       Impact factor: 4.981

4.  Quality of life bibliography and indexes: 1993 update.

Authors:  R A Berzon; G P Simeon; R L Simpson; M A Donnelly; H H Tilson
Journal:  Qual Life Res       Date:  1995-02       Impact factor: 4.147

5.  International development of the Parents' Index of Quality of Life in Atopic Dermatitis (PIQoL-AD).

Authors:  Stephen P McKenna; Diane Whalley; Abigail L Dewar; Ruud A M Erdman; Thomas Kohlmann; Mauro Niero; Eva Baró; Sharon A Cook; Beatrice Crickx; Feride Frech; Daniel van Assche
Journal:  Qual Life Res       Date:  2005-02       Impact factor: 4.147

Review 6.  Neural growth hormone: an update.

Authors:  Steve Harvey; Kerry Hull
Journal:  J Mol Neurosci       Date:  2003-02       Impact factor: 3.444

7.  Visual impairment, visual functioning, and quality of life assessments in patients with glaucoma.

Authors:  R K Parrish
Journal:  Trans Am Ophthalmol Soc       Date:  1996

Review 8.  Growth hormone therapy and quality of life in adults and children.

Authors:  Deborah J Radcliffe; Joseph S Pliskin; J B Silvers; Leona Cuttler
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

9.  Effect of low-normal and high-normal IGF-1 levels on memory and wellbeing during growth hormone replacement therapy: a randomized clinical trial in adult growth hormone deficiency.

Authors:  Christa C van Bunderen; Jan Berend Deijen; Madeleine L Drent
Journal:  Health Qual Life Outcomes       Date:  2018-07-06       Impact factor: 3.186

10.  Psychometric properties of two measures of psychological well-being in adult growth hormone deficiency.

Authors:  Carolyn V McMillan; Clare Bradley; James Gibney; David L Russell-Jones; Peter H Sönksen
Journal:  Health Qual Life Outcomes       Date:  2006-03-22       Impact factor: 3.186

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.